Swissmedic

Type: Organization
Name: Swissmedic
First reported 15 hours ago - Updated 13 hours ago - 1 reports

WHO pools experimental Ebola vaccines as experts scramble to

A batch of experimental Ebola vaccine was today set to arrive in Switzerland from Canada, as researchers scramble to beat the deadly disease which has west Africa in its grip.Marie-Paule Kieny, assistant director general of the World Health Organization, ... [Published Business Standard India - 15 hours ago]
First reported Oct 14 2014 - Updated Oct 14 2014 - 1 reports

‘Ebola is just one of many neglected diseases’

The latest Ebola epidemic to hit West Africa is the worst in history(Keystone)It is the worst Ebola epidemic in history, with West Africa reporting more than 6,600 cases so far. The virus was first found about 40 years ago but neglected as it was considered ... [Published Swiss Info - Oct 14 2014]
First reported Oct 14 2014 - Updated Oct 14 2014 - 1 reports

Toxic drug could threaten Alpine vultures

Indian vultures are a rare sight today because they've almost been wiped out due to diclofenac-contaminated livestock carcasses(Keystone)Even by Swiss standards, the village of La Punt Chamues-ch near St Moritz was the scene of an extraordinary example ... [Published Swiss Info - Oct 14 2014]
First reported Oct 13 2014 - Updated Oct 13 2014 - 1 reports

BRIEF-Cardio3 Biosciences receives authorization from Swissmedic for phase iii trial for C Cure

Oct 13 (Reuters) - Cardio3 Biosciences SA :* Announces authorization from Swissmedic to begincongestive heart failure cardiopoietic regenerative therapy(chart-1) European phase III trial for C-Cure* Expects to finalize recruitment of last patients to ... [Published Reuters UK - Oct 13 2014]
First reported Oct 08 2014 - Updated Oct 08 2014 - 1 reports

ThromboGenics’ Jetrea receives Australia’s TGA approval to treat VMT

Belgium-based ThromboGenics has received approval from the Australia's Therapeutic Goods Administration (TGA), for its Jetrea (ocriplasmin) to treat adults with vitreomacular traction (VMT), including when associated with macular hole of diameter less ... [Published Pharmaceutical Technology - Oct 08 2014]
First reported Sep 30 2014 - Updated Sep 30 2014 - 1 reports

Celgene : Appoints Tuomo Patsi as President of EMEA

Celgene International Sarl , a wholly owned subsidiary of Celgene , has appointed Tuomo Patsi as President of the Europe , Middle East and Africa (EMEA) region for the company.According to a company release, in this role, he will oversee the current portfolio ... [Published 4 Traders - Sep 30 2014]
First reported Sep 24 2014 - Updated Sep 24 2014 - 4 reports

Abraxane Approved in Switzerland for Pancreatic Breast Cancers

Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation (NASDAQ: CELG), announced that Swissmedic, the regulatory authority for Switzerland, has granted approval for Abraxane (paclitaxel formulated as albumin bound nanoparticles, ... [Published BioPortfolio - Sep 24 2014]
First reported Sep 24 2014 - Updated Sep 24 2014 - 1 reports

Celgene Names Tuomo Patsi as President of EMEA

Celgene International Sarl, a wholly owned subsidiary of Celgene, has appointed Tuomo Patsi as President of the Europe, Middle East and Africa (EMEA) region for the company. According to a company release, in this role, he will oversee the current portfolio ... [Published Individual.com - Sep 24 2014]
First reported Sep 23 2014 - Updated Sep 23 2014 - 1 reports

Gift and hospitality thresholds under anti-corruption legislation

IntroductionAnti-corruption legislation CommentIntroductionCorporate policies and procedures on combating corruption often seek to define thresholds for gifts and hospitality. At a higher level, such thresholds draw the line between acceptable and unlawful ... [Published Lexology - Sep 23 2014]
First reported Sep 22 2014 - Updated Sep 22 2014 - 1 reports

Celgene Names EMEA President

Tuomo Pätsi has been appointed president of the Europe, Middle East and Africa (EMEA) region for Celgene International . Mr. Pätsi will oversee the current portfolio in EMEA as well as international efforts for the company’s pipeline of clinical programs ... [Published Contract Pharma - Sep 22 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 1 reports

Newron Pharmaceuticals Reports Half-Year Results 2014

– Newron Pharmaceuticals S.p.A. (“Newron”, SIX: NWRN), a research and development company focused on the development of therapies for patients with Central Nervous System (CNS) and pain disorders, today announces its financial results for the half year ... [Published BioSpace - Sep 16 2014]
First reported Jul 08 2014 - Updated Jul 08 2014 - 1 reports

Swissmedic approves Amitiza for opioidinduced constipation

US biopharma firm Sucampo Pharmaceuticals has received approval from Swissmedic, Switzerland’s Agency for Therapeutic Products, for Amitiza (lubiprostone) 24mcg for the treatment of opioid-induced constipation in adults with chronic, non-cancer pai.. ... [Published BioPortfolio - Jul 08 2014]

Quotes

"We're waiting for the green light from Swissmedic before we get started" hospital spokesman Darcy Christen told AFP, referring to the national regulator
"Jetrea is a truncated form of human plasmin, indicated for treatment of symptomatic vitreomacular adhesion in the US."
He added: "It is an exciting time to work in an industry that is delivering significant innovation and having a direct and sustainable impact on patients, on healthcare and on the economy. My vision as the President for Celgene EMEA is to continue fostering innovative approaches and outcomes for the patients who need our medicines, and we will continue to collaborate with every stakeholder responsible for delivering healthcare, to ensure that patients receive the medicines they need and deserve."
"Public officials are the officials and employees of a public administrative authority or of an authority for the administration of justice, as well as persons who hold office temporarily or are employed temporarily by a public administrative authority or by an authority for the administration of justice or who carry out official functions temporarily."

More Content

All (21) | News (19) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
WHO pools experimental Ebola vaccines as expert... [Published Business Standard India - 15 hours ago]
‘Ebola is just one of many neglected diseases’ [Published Swiss Info - Oct 14 2014]
Toxic drug could threaten Alpine vultures [Published Swiss Info - Oct 14 2014]
BRIEF-Cardio3 Biosciences receives authorizatio... [Published Reuters UK - Oct 13 2014]
ThromboGenics’ Jetrea receives Australia’s TGA ... [Published Pharmaceutical Technology - Oct 08 2014]
A Cancer Drug Reverses the Effects of a Mutant ... [Published Neurology Today - Oct 02 2014]
Celgene : Appoints Tuomo Patsi as President of ... [Published 4 Traders - Sep 30 2014]
Abraxane Approved in Switzerland for Pancreatic... [Published BioPortfolio - Sep 24 2014]
Celgene Announces The Swissmedic Approval Of AB... [Published BioSpace - Sep 24 2014]
Abraxane Approved in Switzerland for Pancreatic... [Published Drug Discovery and Development - Sep 24 2014]
Celgene Announces the Swissmedic Approval of AB... [Published Business Wire Health News - Sep 24 2014]
Celgene Names Tuomo Patsi as President of EMEA [Published Individual.com - Sep 24 2014]
Gift and hospitality thresholds under anti-corr... [Published Lexology - Sep 23 2014]
Celgene Names EMEA President [Published Contract Pharma - Sep 22 2014]
Newron Pharmaceuticals Reports Half-Year Result... [Published BioSpace - Sep 16 2014]
Swissmedic approves Amitiza for opioidinduced c... [Published BioPortfolio - Jul 08 2014]
Swissmedic Approves AMITIZA(R) (Lubiprostone) f... [Published GlobeNewswire: Acquisitions News - Jul 07 2014]
CHMP recommends approval of Vertex's Kalydeco f... [Published PharmaBiz - Jul 01 2014]
Newron, Zambon seek marketing nod for Parkinson... [Published PharmaBiz - Apr 09 2014]
Swissmedic approves ThromboGenics' Jetrea for v... [Published PharmaBiz - Mar 20 2014]
Swiss Agency approves ThromboGenics' Jetrea to ... [Published Pharmaceutical Business Review - Mar 19 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Celgene Announces the Swissmedic Approval of AB... [Published Business Wire Health News - Sep 24 2014]
BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that Swissmedic, the regulatory authority for Switzerland, has granted approval for ABRAXANE® (paclitaxel ...
1

Press Releases

sort by: Date | Relevance
Swissmedic Approves AMITIZA(R) (Lubiprostone) f... [Published GlobeNewswire: Acquisitions News - Jul 07 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.